SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include MedPage Today, HCPLive, News-Medical and Medscape. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 1h ago.
Quick answers
Why is "SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate " trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds Medical Xpress · 15h ago
- DOACs Benefit AF Patients With Intermediate Stroke Risk: SINGLE-AF TCTMD.com · 15h ago
- First Major Trial Win for Contemporary DOACs in Lower-Risk Afib MedPage Today · 15h ago
- SINGLE-AF: Oral Anticoagulants Reduce Risk of Stroke in Patients With AF HCPLive · 15h ago
- Oral anticoagulants benefit patients with atrial fibrillation at intermediate stroke risk News-Medical · 15h ago
- DOACs Benefit AF Patients With Intermediate Stroke Risk Medscape · 15h ago
- SINGLE-AF: DOAC Therapy vs. No Anticoagulation in AFib Patients at Intermediate Risk For Stroke American College of Cardiology · 15h ago
Topics
Related trends
New Inclisiran Therapy Shows Reduction in LDL Cholesterol
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.